Viewing Study NCT00126594


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2025-12-31 @ 10:49 AM
Study NCT ID: NCT00126594
Status: COMPLETED
Last Update Posted: 2016-09-16
First Post: 2005-08-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
Sponsor: National Cancer Institute (NCI)
Organization: